STOCK TITAN

CLS HOLDINGS USA INC (CLSH) Financials

CLSH
Trailing 12 months to February 28, 2025
Revenue $17.5M -15.7% YoY
Net Income $460K +104.8% YoY
EPS (Diluted) $0.01 YoY not available
Free Cash Flow $425K -67.7% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Feb 28, 2025 Reported Currency USD FYE May

Newest figures come from the 10-Q for Q3 FY2025, filed Apr 14, 2025. Each column of the statement tables below links to the filing it was taken from.

CLS HOLDINGS USA INC (CLSH) reported $17.5M in revenue over the twelve months to Feb 28, 2025, down 15.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CLSH FY2024

Positive cash flow despite losses coexists with liability-heavy financing, while lower sales expose weakening gross economics.

In FY2024, cash conversion improved: operating cash flow and free cash flow both turned positive even as net income remained a $4.5M loss, showing that reported earnings and cash movement were being driven by different items, such as noncash charges or working-capital changes. The shift from negative cash generation in FY2023 to positive cash generation in FY2024 marks reduced immediate funding pressure, but it does not establish recurring profitability.

Lower sales coincided with gross-margin compression to 42.7% from 45.7%, indicating weaker unit economics rather than merely fewer sales. The operating loss nevertheless narrowed to $2.0M from $3.8M as selling, general and administrative spending declined, so expense control partly offset gross-profit pressure.

The balance sheet remains structurally liability-heavy: liabilities substantially exceeded assets, leaving negative equity, while a 0.2x current ratio indicates current assets covered only a fraction of near-term obligations. Debt fell to $6.8M from $12.0M, reducing one pressure point without repairing the broader balance-sheet deficit.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

CLS HOLDINGS USA INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress
-19.82

CLS HOLDINGS USA INC scores -19.82, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($5.9M) relative to total liabilities ($20.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

CLS HOLDINGS USA INC passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

CLS HOLDINGS USA INC reported a net loss of $4.5M while generating $809K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

CLS HOLDINGS USA INC reported an operating loss of $2.0M against $1.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$3.9M
YoY-21.8%
QoQ-7.4%
5Y CAGR+3.6%

CLS HOLDINGS USA INC generated $3.9M in revenue in Q3 2025. This represents a decrease of 21.8% from the same quarter a year earlier. Against the prior quarter it is down 7.4%.

EBITDA
-$277K
YoY-1.5%
QoQ-37.8%

CLS HOLDINGS USA INC's EBITDA was -$277K in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.5% from the same quarter a year earlier. Against the prior quarter it is down 37.8%.

Net Income
-$279K
YoY+93.6%
QoQ-218.1%

CLS HOLDINGS USA INC reported -$279K in net income in Q3 2025. This represents an increase of 93.6% from the same quarter a year earlier. Against the prior quarter it is down 218.1%.

EPS (Diluted)
$0.00
YoY+100.0%

CLS HOLDINGS USA INC earned $0.00 per diluted share (EPS) in Q3 2025. This represents an increase of 100.0% from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow
-$150K
YoY+64.5%
QoQ-175.0%

CLS HOLDINGS USA INC recorded an outflow of $150K in free cash flow in Q3 2025, representing a cash shortfall after capex. This represents an increase of 64.5% from the same quarter a year earlier. Against the prior quarter it is down 175.0%.

Cash & Debt
$221K
YoY-68.4%
QoQ-62.8%
5Y CAGR-40.8%

CLS HOLDINGS USA INC held $221K in cash against $3.2M in long-term debt as of Q3 2025.

Shares Outstanding
165M
YoY+19.7%
QoQ0.0%
5Y CAGR+5.4%
10Y CAGR+30.8%

CLS HOLDINGS USA INC had 165M shares outstanding in Q3 2025. This represents an increase of 19.7% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q3 2025.

Margins & Returns

Gross Margin
40.0%
YoY-3.1pp
QoQ-2.5pp
5Y change-12.3pp

CLS HOLDINGS USA INC's gross margin was 40.0% in Q3 2025, indicating the percentage of revenue retained after direct costs. This is down 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.5 percentage points.

Operating Margin
-10.2%
YoY-1.3pp
QoQ-2.4pp
5Y change+6.2pp

CLS HOLDINGS USA INC's operating margin was -10.2% in Q3 2025, reflecting core business profitability. This is down 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.4 percentage points.

Net Margin
-7.2%
YoY+81.5pp
QoQ-5.1pp
5Y change+31.6pp

CLS HOLDINGS USA INC's net profit margin was -7.2% in Q3 2025, showing the share of revenue converted to profit. This is up 81.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.1 percentage points.

Return on Equity

Not reported for Q3 2025.

Capital Allocation

R&D Spending
$180
YoY-86.0%
QoQ-35.9%

CLS HOLDINGS USA INC invested $180 in research and development in Q3 2025. This represents a decrease of 86.0% from the same quarter a year earlier. Against the prior quarter it is down 35.9%.

Capital Expenditures
$3K
YoY-56.8%
QoQ-82.8%
5Y CAGR-57.5%

CLS HOLDINGS USA INC invested $3K in capex in Q3 2025, funding long-term assets and infrastructure. This represents a decrease of 56.8% from the same quarter a year earlier. Against the prior quarter it is down 82.8%.

Share Buybacks

Not reported for Q3 2025.

CLSH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLSH quarterly income statement
MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Revenue$3.9M-21.8%$4.2M-19.9%$4.8M-6.0%$4.7M-15.3%$4.9M-9.4%$5.2M-14.4%$5.1M-15.4%$5.6M-9.5%
Cost of Revenue$2.3M-17.4%$2.4M-21.0%$2.8M-2.9%$2.8M-18.2%$2.8M-2.5%$3.0M-3.9%$2.8M-9.7%$3.4M-18.9%
Gross Profit$1.5M-27.4%$1.8M-18.4%$2.0M-9.9%$1.9M-10.8%$2.1M-17.1%$2.2M-25.8%$2.3M-21.6%$2.2M+10.4%
R&D Expenses$180-86.0%$281-34.8%$140-90.4%$1K+1347.1%$1K+556.1%$431-36.9%$1K-$70-98.6%
SG&A Expenses$1.9M-24.5%$2.1M-19.6%$2.2M-20.0%$2.6M-12.3%$2.6M+6.5%$2.6M-24.0%$2.7M-10.8%$3.0M+54.7%
Operating Income-$393K+10.3%-$323K+25.8%-$137K+70.1%-$667K+79.5%-$438K-377.8%-$435K+13.5%-$456K-184.8%-$3.3M-6622.5%
EBITDA-$277K-1.5%-$201K+25.3%-$2K+99.3%-$335K+88.9%-$273K-168.8%-$269K-1.1%-$290K-476.8%-$3.0M-1224.0%
Interest Expense$115K-53.7%$296K-28.0%$159K-65.2%$782K+21.7%$248K-61.8%$411K-32.5%$457K-40.3%$642K-12.4%
Income Tax$443K-0.9%$469K+2.8%$525K+9.9%$767K+14.7%$447K-13.5%$456K-11.7%$478K-8.0%$669K-46.4%
Net Income-$279K+93.6%-$88K+93.3%-$821K-77.0%$1.6M+146.6%-$4.4M-385.7%-$1.3M+84.1%-$464K+59.6%-$3.5M-146.7%
EPS (Basic)$0.00+100.0%$0.00+100.0%-$0.010.0%$0.02+140.0%-$0.04-300.0%-$0.02+83.3%-$0.01+75.0%-$0.050.0%
EPS (Diluted)$0.00+100.0%$0.00+100.0%-$0.01$0.02+140.0%-$0.04-$0.02+83.3%-$0.01-$0.05
Diluted Shares (Avg)165M+38.9%167M+130.5%125MN/A119M73M+10.2%73MN/A

CLSH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLSH quarterly balance sheet
MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Total Assets$7.0M-23.7%$7.9M-26.3%$10.9M+6.3%$7.9M-21.3%$9.1M-36.5%$10.7M-31.1%$10.3M-32.8%$10.1M-36.4%
Current Assets$2.9M-29.8%$3.6M-33.6%$6.4M+29.0%$3.3M-28.1%$4.1M-32.9%$5.4M-22.5%$5.0M-16.7%$4.6M-33.3%
Cash & Equivalents$221K-68.4%$593K-66.3%$521K-49.6%$600K-39.9%$699K-21.3%$1.8M+117.6%$1.0M+74.8%$998K-60.9%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$1.4M-42.2%$1.8M-31.7%$2.0M-33.2%$2.0M-34.7%$2.4M-45.1%$2.6M-45.8%$3.1M-27.6%$3.0M-11.8%
Accounts Receivable$1.2M+29.2%$1.2M+23.5%$1.2M+60.2%$683K+58.4%$954K+32.8%$933K-7.2%$758K+2.6%$431K-30.3%
Long-Term Investments$0$0$0$0$0-100.0%$0-100.0%$0-100.0%$0-100.0%
Goodwill$558K0.0%$558K0.0%$558K0.0%$558K0.0%$558K0.0%$558K0.0%$558K0.0%$558K0.0%
Total Liabilities$19.5M-5.5%$20.2M-23.0%$22.4M-8.6%$20.8M-12.7%$20.6M-13.6%$26.2M+9.1%$24.5M-27.3%$23.9M-27.6%
Current Liabilities$17.5M+29.2%$16.7M-14.1%$16.2M-7.1%$14.2M-12.9%$13.5M-16.8%$19.5M+69.8%$17.4M-39.4%$16.3M-41.9%
Non-Current Liabilities$2.0M-71.5%$3.5M-48.6%$6.2M-12.2%$6.6M-12.3%$7.1M-6.9%$6.7M-46.3%$7.1M+42.5%$7.5M+54.8%
Long-Term Debt$3.2M-55.4%$4.0M-68.0%$6.9M-40.8%$6.8M-43.2%$7.1M-41.7%$12.5M+1.8%$11.7M-50.7%$12.0M-49.7%
Total Equity-$11.4M-9.9%-$11.1M+22.4%-$10.4M+21.0%-$11.8M+7.0%-$10.4M-13.7%-$14.4M-74.6%-$13.1M+27.9%-$12.7M+25.8%
Retained Earnings-$114.6M+0.4%-$114.3M-3.3%-$114.2M-4.4%-$113.4M-4.1%-$115.0M-9.2%-$110.6M-5.9%-$109.3M-13.6%-$108.9M-14.5%

CLSH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLSH quarterly cash flow statement
MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Operating Cash Flow-$147K+64.6%$216K-2.4%$252K-67.8%$220K-72.1%-$416K-151.8%$221K+161.6%$783K+153.6%$789K+231.4%
Depreciation & Amortization$116K-29.8%$122K-26.6%$134K-19.2%$332K+40.8%$165K-30.8%$166K-29.8%$166K-29.7%$236K+8.1%
Stock-Based Compensation$29K$23K$29KN/AN/AN/A$0N/A
Capital Expenditures$3K-56.8%$16K-31.5%$0-100.0%$97K+801.5%$6K+114.5%$24K-53.1%$21K-76.6%$11K-98.8%
Free Cash Flow-$150K+64.5%$200K+1.1%$252K-66.9%$122K-84.3%-$422K-152.8%$198K+148.3%$763K+149.2%$778K+150.5%
Investing Cash Flow-$3K-123.5%-$16K+31.5%$0+100.0%-$57K-222.7%$12K+120.6%-$24K-104.6%-$79K+85.5%-$18K+98.2%
Financing Cash Flow-$222K+66.2%-$2.7M-617.6%$2.3M+439.6%-$261K+60.4%-$657K+1.4%$527K+722.8%-$668K-1514.2%-$660K-197.7%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CLSH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLSH quarterly financial ratios
MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Gross Margin40.0%-3.1pp42.6%+0.8pp42.6%-1.8pp41.2%+2.1pp43.2%-4.0pp41.8%-6.4pp44.5%-3.5pp39.1%+7.0pp
Operating Margin-10.2%-1.3pp-7.8%+0.6pp-2.8%+6.1pp-14.1%+44.2pp-8.9%-11.8pp-8.4%-0.1pp-8.9%-6.3pp-58.4%-59.2pp
Net Margin-7.2%+81.5pp-2.1%+22.9pp-17.1%-8.0pp34.9%+98.3pp-88.7%-72.2pp-25.1%-9.1%+9.9pp-63.4%-40.1pp
Return on Assets-4.0%+43.9pp-1.1%+11.1pp-7.5%-3.0pp20.8%+55.9pp-47.9%-41.6pp-12.2%+40.8pp-4.5%+3.0pp-35.1%-26.1pp
Current Ratio0.17-0.1x0.21-0.1x0.40+0.1x0.230.0x0.30-0.1x0.28-0.3x0.28+0.1x0.280.0x
Asset Turnover0.550.0x0.530.0x0.44-0.1x0.600.0x0.54+0.2x0.49+0.1x0.50+0.1x0.55+0.2x
FCF Margin-3.9%+4.7pp4.8%+1.0pp5.3%-9.7pp2.6%-11.4pp-8.6%-23.3pp3.8%+10.6pp14.9%+40.6pp14.0%+38.9pp

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Note: Shareholder equity is negative (-$11.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.23), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
CLS HOLDINGS USA INC CLSH FY2024 $20.0M -$4.5M -22.5% $5.9M —
CORDOVACANN CORP LVRLF FY2021 N/A -$2.6M N/A $2.2M —
CV SCIENCES INC CVSI FY2025 $13.8M -$958K -7.0% $3.3M —

Frequently Asked Questions

What is CLS HOLDINGS USA INC's annual revenue?

CLS HOLDINGS USA INC (CLSH) reported $20.0M in total revenue for fiscal year 2024. This represents a -13.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CLS HOLDINGS USA INC's revenue growing?

CLS HOLDINGS USA INC (CLSH) revenue declined by 13.7% year-over-year, from $23.1M to $20.0M in fiscal year 2024.

Is CLS HOLDINGS USA INC profitable?

No, CLS HOLDINGS USA INC (CLSH) reported a net income of -$4.5M in fiscal year 2024, with a net profit margin of -22.5%.

CLS HOLDINGS USA INC (CLSH) reported diluted earnings per share of -$0.05 for fiscal year 2024. This represents a 78.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CLS HOLDINGS USA INC (CLSH) had EBITDA of -$1.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2024, CLS HOLDINGS USA INC (CLSH) had $600K in cash and equivalents against $6.8M in long-term debt.

CLS HOLDINGS USA INC (CLSH) had a gross margin of 42.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

CLS HOLDINGS USA INC (CLSH) had an operating margin of -10.0% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

CLS HOLDINGS USA INC (CLSH) had a net profit margin of -22.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

CLS HOLDINGS USA INC (CLSH) generated $661K in free cash flow during fiscal year 2024. This represents a 272.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

CLS HOLDINGS USA INC (CLSH) generated $809K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

CLS HOLDINGS USA INC (CLSH) had $7.9M in total assets as of fiscal year 2024, including both current and long-term assets.

CLS HOLDINGS USA INC (CLSH) invested $148K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

CLS HOLDINGS USA INC (CLSH) invested $4K in research and development during fiscal year 2024.

CLS HOLDINGS USA INC (CLSH) had 125M shares outstanding as of fiscal year 2024.

CLS HOLDINGS USA INC (CLSH) had a current ratio of 0.23 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

CLS HOLDINGS USA INC (CLSH) had a return on assets of -56.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

CLS HOLDINGS USA INC (CLSH) has negative shareholder equity of -$11.8M as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

CLS HOLDINGS USA INC (CLSH) has an Altman Z-Score of -19.82, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

CLS HOLDINGS USA INC (CLSH) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

CLS HOLDINGS USA INC (CLSH) reported a net loss of $4.5M while generating $809K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

CLS HOLDINGS USA INC (CLSH) reported an operating loss of $2.0M against $1.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top